HLN · Pharma and healthcare · one day
Haleon (HLN): news on Thursday 12 November 2026
News from the 24 hours to Thursday morning, 12 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage centred on analyst reaction to the lowered guidance following the third-quarter trading update, with RBC critical of the outlook but keeping a neutral rating. A few more upbeat pieces on execution and brand marketing partly offset the cautious tone.
What drove it
- guidance cut
- RBC rating
- Q3 trading update
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Fri 6 Nov | −2.8 | 5 |
| Mon 9 Nov | −1.7 | 2 |
| Tue 10 Nov | +5.7 | 3 |
| Wed 11 Nov | −6.3 | 3 |
| Thu 12 Nov | −3.3 | 7 |
| Fri 13 Nov | +0.5 | 1 |
4 stories · 7 headlines · strongest first
Pharma and healthcare on 12 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Haleon outlook after Q3 slowdown −2.93 headlines today · 12 in all, since 4 November · Pieces ask whether to buy Haleon and whether execution will redefine its story. | ||
| +5.8 | Analyst view that shares can beat the market if consumer staples stay resilient.the | |
| +1.7 | Commentary on delivery being central to the investment case; mildly constructive. | |
| +0.8 | General investor advice piece on whether to buy the shares. | |
| RBC maintains Sector Perform rating on Haleon following Q3 −3.32 headlines today · RBC kept Sector Perform, saying execution is fine but guidance is not. | ||
| −5.8 | Broker considers operations sound but is unhappy with the revised outlook. | |
| −0.8 | Broker leaves its neutral rating unchanged after the quarterly update. | |
| Haleon lowers its 2026 growth outlook following soft third quarter −10.01 headline today · 61 in all, since 30 October · A piece calls the guidance cut a test for Haleon shares. | ||
| −8.3 | Lowered outlook seen as a significant challenge for the share price. | |
| Haleon brings drugstore staples to soccer in US +5.01 headline today · Haleon US is promoting products around soccer. | ||
| +5.0 | Marketing partnership with soccer raising brand visibility in the US. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Haleon: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.